Artesunate suppositories work with artemisinin suppositories in severe malaria was conducted in Viet Nam in the early 1990s, and clinical trials of rectal artesunate followed by mefloquine treatment in moderately severe malaria were conducted in the mid-1990s in Thailand. A major placebo-controlled clinical trial published in 2009 found that "if patients with severe malaria cannot be treated orally and access to injections will take several hours, a single inexpensive artesunate [rectal] suppository at the time of referral substantially reduces the risk of death or permanent disability." Artesunate suppositories Artesunate suppositories are used for the treatment of malaria. Artesunate is an antimalarial water-soluble
International Association for the Treatment of Sexual Offenders either individual, couple, family, or even group settings. The treatments offered are created and used to prevent any offending behavior and further victimization of others. The biomedical treatment is the use of pharmacological treatment. This type of therapy in the past has included the use of anti-androgens, antidepressants, and anti-anxiety, anti epileptic, antipsychotic, or other types of medicine. However, note that biomedical treatment is not limited to these medications. All medications have different turnouts for different individuals, so it is crucial to find the best fit and the most successful medication for that specific person to help treat them and